After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Diagnostics & Research industry segment, falling under the Healthcare sector. The current market capitalization of Myriad Genetics, Inc is $1.35B. A total of 0.93 million shares were traded on the day, compared to an average of 940.88K shares.
In the most recent transaction, DIAZ PAUL J sold 15,000 shares of MYGN for 22.93 per share on Oct 11 ’24. After the transaction, the President and CEO now owns 962,378 company shares. In a previous transaction on Oct 11 ’24, DIAZ PAUL J bought 15,000 shares at 22.93 per share.
Among the insiders who bought shares, Ancona Margaret acquired of 11,538 shares on Aug 21 ’24 at a per-share price of $27.82. In another insider transaction, DIAZ PAUL J sold 15,000 shares at $26.72 per share on Sep 11 ’24. Company shares held by the President and CEO now total 977,378.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, MYGN has a high of $29.30 and a low of $12.87.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MYGN’s latest balance sheet shows that the firm has $338.80M in Cash & Short Term Investments as of fiscal 2021. There were $92.30M in debt and $204.30M in liabilities at the time. Its Book Value Per Share was $8.04, while its Total Shareholder’s Equity was $967.80M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MYGN is Buy with a score of 3.47.
